Exploring the emergence of agentic ecosystems in transforming data accessibility and ensuring reliable answers reach the people making decisions while there is still a choice to make.
Kapil Chaddha
Advertisement
Senior director, new product development at IQVIA. Brings more than 22 years of experience in leadership and operational roles across pharmaceutical, healthcare, financial services and automotive industries. As director of New Product Development at IQVIA, he leads product development within Global Market Insights, driving development and commercialization of GenAI solutions while also transforming the flagship IQVIA MIDAS® offering for global pharmaceutical market measurement. His expertise spans end-to-end client engagement management, business development and solution design for complex business challenges across Fortune 500 customers in the U.S., U.K., Europe and APAC regions.
Articles by Kapil Chaddha
Agentic AI is reshaping pharma market entry by enabling real-time, data-driven insights that allow companies to ask more complex strategic questions and act faster — with greater precision.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Grants Ultomiris Accelerated Approval in the U.S. for Adults with Primary Immunoglobulin A Nephropathy
2
FDA Approves Hibsago (Bepirovirsen) for Chronic Hepatitis B
3
Median Drug Launch Prices Hit $257,000 as Access Barriers Persist, ICER and West Health Report Finds
4
CSL Names Deborah Waterhouse as CEO and Manager Director
5